Anteilseigner
Versant Venture Management LLC (17,74 %) NEA Management Co. LLC (15,34 %) Fidelity Management & Research Co. LLC (10,65 %) T. Rowe Price Associates, Inc. (Investment Management) (10,08 %) Baker Bros. Advisors LP (9,80 %) Avoro Capital Advisor LLC (9,04 %) BlackRock Fund Advisors (3,74 %) The Vanguard Group, Inc. (3,21 %) Aisling Capital Management LP (2,94 %) HBM Partners AG (Investment Management) (2,81 %) Citadel Advisors LLC (1,95 %) Geode Capital Management LLC (1,47 %) SSgA Funds Management, Inc. (1,23 %) Casdin Capital LLC (1,02 %) BlackRock Advisors LLC (0,66 %) Northern Trust Investments, Inc.(Investment Management) (0,58 %) ExodusPoint Capital Management LP (0,53 %) Charles Schwab Investment Management, Inc. (0,50 %)
Kontakt
Monte Rosa Therapeutics Inc.